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Abstract
Background: Tobacco smoke is the principal risk factor for chronic obstructive pulmonary disease
(COPD), though the mechanisms of its toxicity are still unclear. The ABC transporters multidrug
resistance-associated protein 1 (MRP1) and P-glycoprotein (P-gp/MDR1) extrude a wide variety of toxic
substances across cellular membranes and are highly expressed in bronchial epithelium. Their impaired
function may contribute to COPD development by diminished detoxification of noxious compounds in
cigarette smoke.
Methods: We examined whether triple knock-out (TKO) mice lacking the genes for Mrp1 and Mdr1a/1b
are more susceptible to develop COPD features than their wild-type (WT) littermates. TKO and WT
mice (six per group) were exposed to 2 cigarettes twice daily by nose-only exposure or room air for 6
months. Inflammatory infiltrates were analyzed in lung sections, cytokines and chemokines in whole lung
homogenates, emphysema by mean linear intercept. Multiple linear regression analysis with an interaction
term was used to establish the statistical significances of differences.
Results: TKO mice had lower levels of interleukin (IL)-7, KC (mouse IL-8), IL-12p70, IL-17, TNF-alpha,
G-CSF, GM-CSF and MIP-1-alpha than WT mice independent of smoke exposure (P < 0.05). IL-1-alpha,
IL-6, IL-8, IL-13, IL-17, TNF-alpha, G-CSF, GM-CSF and MCP-1 increased after smoke exposure in both
groups, but the increase in IL-8 was lower in TKO than WT mice (P < 0.05) with a same trend for G-CSF
(P < 0.10). Smoke-induced increase in pulmonary inflammatory cells in WT mice was almost absent in TKO
mice. The mean linear intercept was not different between groups.
Conclusion: Mrp1/Mdr1a/1b knock-out mice have a reduced inflammatory response to cigarette smoke.
In addition, the expression levels of several cytokines and chemokines were also lower in lungs of Mrp1/
Mdr1a/1b knock-out mice independent of smoke exposure. Further studies are required to determine
whether dysfunction of MRP1 and/or P-gp contribute to the pathogenesis of COPD.
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Background
Tobacco smoke generates oxidative stress in the lungs and
is the principal risk factor for the development of chronic
obstructive pulmonary disease (COPD). Main features of
COPD are airway inflammation and destruction of alveo-
lar tissue. Little is known about detoxification and elimi-
nation processes of noxious substances present in
cigarette smoke. Proteins of the ATP-binding cassette
(ABC) superfamily such as multidrug resistance-associ-
ated protein 1 (MRP1) and P-glycoprotein (P-gp, encoded
by the MDR1 gene) protect against oxidative stress, chem-
otherapeutic drugs and xenobiotics [1,2] by transporting
a wide variety of toxic substances across cellular mem-
branes. MRP1 and P-gp are highly expressed in human
and mouse lung and are mainly located at the basolateral
and apical side of bronchial epithelium respectively [3,4].
So far, the function of these ABC transporters in the lung
is unknown [5]. They possibly detoxify carcinogenic com-
pounds and other noxious gasses and particles present in
tobacco smoke [6]. Thus a defective function may play a
role in the pathogenesis of lung cancer and COPD.
Mrp1  (-/-) and Mdr1a/1b  (-/-) mice (in contrast to
humans, rodents have two genes for P-gp, called Mdr1a
and Mdr1b), are healthy and fertile under normal condi-
tions [7,8]. Mice that lack Mrp1 and both Mdr1a/1b genes,
from here on called triple knock-out (TKO) mice, seem
physiologically normal as well [9]. However, all these
knock-out mice are highly sensitive to several chemother-
apeutic drugs. In addition,Mrp1  (-/-) mice display ele-
vated glutathione levels in tissues that normally have a
high MRP1 expression, e.g. in the lungs [7], possibly as a
compensation mechanism for the elevated pulmonary
oxidative stress. Furthermore, these mice have an
impaired inflammatory response [10] that is probably
due to lower leukotriene C4 (LTC4, a proinflammatory
mediator) excretion by macrophages or granulocytes since
LTC4 is a physiologic substrate for MRP1 [11].
We detected lower MRP1 expression in bronchial epithe-
lium of COPD patients compared to healthy ex-smokers
[12]. In the present study, we investigated whether TKO
mice have a different susceptibility to develop cigarette
smoke-induced features of COPD compared to their wild-
type (WT) littermates.
Methods
Mice
WT male FVB mice were obtained from Harlan (Zeist, the
Netherlands). Male FVB Mrp1/Mdr1a/1b TKO mice were
kindly provided by Drs AH Schinkel and P Borst, the
Netherlands Cancer Institute, Amsterdam [13]. Mice were
held at the central animal facility of the University of Gro-
ningen. The animals received standard rodent food (Hope
Farms, Woerden, The Netherlands) and water ad libitum.
Experiments were approved by the local committee on
animal experimentation, and were performed under strict
governmental and international guidelines.
Smoke exposure
Mainstream smoke of research cigarettes (type 2R1, Uni-
versity of Kentucky, KY) was administered by nose-only
exposure [14]. The smoke exposure system of the Univer-
sity of Kentucky was used and the system was set up
according to instructions of the manufacturer. Six mice
per experimental group were exposed to 2 cigarettes per
session, 10 puffs per cigarette, twice daily for 5 days per
week. Sham control mice were room air-exposed in a sep-
arate animal exposure subunit under similar circum-
stances.
Preparation of lungs
After 6 months smoke or air exposure, the mice were anes-
thetized with a mixture of isoflurane, N2O, and oxygen,
and the trachea was cannulated. Subsequently, the mice
were exsanguinated via the abdominal aorta. The right
lung was ligated and lung lobes were snap-frozen and
stored at -80°C. The left lung was removed, inflated and
fixed with formalin with a constant pressure of 25 cm
H2O for 24 h. Subsequently, the lung was dissected from
the trachea and embedded in paraffin for immunohisto-
chemical evaluation and morphometrical analysis [15].
Morphometrical measurements of emphysema
Three-micron paraffin sections were cut and stained with
hematoxylin and eosin (H&E) according to standard
methods. Approximately 25 photomicroscopic images
per tissue section were prepared at 2.5 × 20 magnifications
using a standardized sequence of image capturing. Images
with large vessels, conducting airways or pleura occupying
25% or more of the total image were not used for the
mean linear intercept (Lmi) analysis which was assessed
as a measure of alveolar airspace enlargement by two
independent individuals in a blinded manner [15,16].
Mean values per mouse were used for statistical analysis.
Cytokine and chemokine analysis in lung homogenates
One part of frozen lung tissue (17 to 30 mg) of each
mouse was homogenized in buffer (50 mM Tris-HCl, 150
mM NaCl, 0.002% Tween-20, pH = 7.5) in 10% w/v for 1
to 2 min and subsequently centrifuged for 10 min, 12,000
g at 4°C. Supernatants were stored at -80°C until analysis.
Cytokines and chemokines that might play a role in cellu-
lar defense mechanisms against cigarette smoke or smoke-
induced cellular damage were measured by means of a
multiplex Luminex ELISA system (Lincoplex Systems, St
Charles, MO). These included: interleukin (IL)-1α, IL-1β,
IL-2, IL-4, IL-5, IL-6, IL-7, keratinocyte chemoattractant
(KC, murine homologue of IL-8), IL-9, IL-10, IL-12p70,
IL-13, IL-15, IL-17, tumor necrosis factor-alpha (TNFα),Respiratory Research 2007, 8:49 http://respiratory-research.com/content/8/1/49
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interferon-gamma (IFNγ), granulocyte-colony stimulating
factor (G-CSF), granulocyte-macrophage-colony stimulat-
ing factor (GM-CSF), IFN-inducible protein-10 (IP-10),
MCP-1 (monocyte chemoattractant protein-1), macro-
phage inflammatory protein 1-alpha (MIP1α) and regu-
lated upon activation, normal T-cell expressed and
secreted (RANTES). The concentrations of cytokines and
chemokines were expressed as pg/g total lung tissue.
Immunohistochemical analysis of infiltrates in lung tissue
The presence of inflammatory cells in paraffin embedded
lung sections (3 µm) was evaluated with a semi-quantita-
tive score. The total number of infiltrates in three different
sections of each lung were counted. The infiltrates were
mainly clustered together in groups, not as single cells.
Clusters of 25 cells or more were considered positive. Of
every mouse lung, the infiltrates in three sections were
averaged and the average per experimental group (4–6
mice) was calculated. All sections were cut in a similar
way, i.e. in the same plane and 250 micrometer from the
start of sectioning of the tissue. In this way, the counting
area was similar in all sections.
Specific monoclonal antibodies anti-Neutrophil (Cedar-
lane, Sanbio, Uden, The Netherlands), MAC-3 and B220
(both from BD Pharmingen, San Jose, CA) were used to
detect the presence of neutrophils, macrophages, and B-
cells respectively. Detection of these antibodies was per-
formed using biotin-labeled rabbit-anti-rat antibodies
(SouthernBiotech, ITK, Uithoorn, The Netherlands) as the
second step and alkaline phosphatase-labeled streptavi-
din (Dako, Glostrup, Denmark) as the third step. New
fuchsin (Dako, Glostrup, Denmark) was used as a chro-
mogen and methyl green for nuclear counterstaining.
Frozen sections were stored at -20°C until use. After thaw-
ing, slides were incubated in acetone for 10 min. Subse-
quently, sections were incubated with specific antibodies
for CD3, CD4 and CD8-positive T-cells (antibodies from
BD Pharmingen). Detection of CD4 and CD8 antibodies
was performed using biotin-labeled goat-anti-rat antibod-
ies as the second step. Anti mouse-CD3 polyclonal serum
(from hamster) was detected by polyclonal biotin-labeled
mouse-anti-hamster antibodies (BD Pharmingen) and the
third step was streptavidin-peroxidase complex (Dako,
Glostrup, Denmark). Amino-ethyl carbazole (AEC)
(Sigma Aldrich, Zwijndrecht, The Netherlands) was used
as chromogen, and hematoxylin was used for nuclear
counterstaining. All incubation steps were carried out at
room temperature. PBS/1% BSA or irrelevant isotype spe-
cific antibodies were used as negative controls. Mouse
spleen was used as positive control.
Statistical analysis
All data are expressed as the mean ± SD. Multiple linear
regression analysis with an interaction term was used to
establish the statistical significances of differences in
terms of genotype (TKO or WT) and cigarette smoke expo-
sure for each parameter. This method disentangles the
separate effects of cigarette smoke and genotype and their
interaction. A significant interaction indicates that the
effect of the combination is significantly different (larger
or smaller) than the addition of the separate effects of
smoke exposure and the genotype. When the interaction
term was significant, the regression coefficients of the sep-
arate effects of smoking and of genotype were taken from
this model. In cases of no significant interaction, the inter-
action term was removed from the analysis and the coef-
ficients were taken from the model with only smoking
and genotype. The normal distribution was tested with a
Kolmogorov-Smirnov test and data were logarithmically
transformed when needed to normalize distributions. A
value of P < 0.05 was considered significant. Statistical
analyses were performed with SPSS 10 (SPSS Inc, Chicago,
IL).
Results
Two sham control mice of the WT group died of unknown
cause in the last month before ending the experiment.
Autopsy did not reveal specific pathology, in particular no
indications of infection. Malignancies were not observed
in lungs of either WT or TKO mice.
Cytokines and chemokines
Levels of IL-7, IL-8, IL-12p70, IL-17, TNFα, G-CSF, GM-
CSF and MIP1α in whole lung homogenates were signifi-
cantly lower in TKO mice than WT mice independent of
smoke exposure (Table 1). After 6 months smoke expo-
sure, IL-1α, IL-6, IL-8, IL-13, IL-17, TNFα, G-CSF, GM-CSF
and MCP-1 in lungs of mice were elevated in TKO and WT
mice (Table 1). The results of IL-8, G-CSF, TNFα, and
MIP1α measurements are depicted in Figure 1A–D. The
increase of IL-8 in response to smoke was less in TKO mice
compared to WT mice (P = 0.047), with a similar trend for
G-CSF production (P  = 0.096) (Figure 1 and Table 1,
smoke × genotype interaction term).
Evaluation of inflammatory cells and emphysema
There were significantly lower numbers of lymphoid
inflammatory cells in the paraffin lung sections of smoke-
exposed TKO mice as compared to WT mice (P = 0.02)
(Figure 2). Lymphoid infiltrates as well as pigmented
(smoke particles positive) macrophages could be distin-
guished. Representative pictures are shown in Figure 3.
Almost no infiltrates were detected in the lungs of TKO
and WT mice that were not exposed to smoke. The lym-
phoid infiltrates consisted mainly of B-cells surrounded
by CD4 positive and CD8 positive cells and their relativeRespiratory Research 2007, 8:49 http://respiratory-research.com/content/8/1/49
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distribution was comparable between WT and TKO
smoke-exposed mice. Neutrophils were present in very
low numbers in all experimental groups and were not fur-
ther analyzed.
Mean Lmi values ranged from 18.3 to 23.5 µm (Figure 4).
There was a slight increase of airspace size after 6 months
smoke exposure in both TKO and WT mice. However, no
significant differences in Lmi values were measured
between the four groups. The body weight of the mice was
not significantly different between the groups before and
after smoke exposure.
Discussion
Our data show that the inflammatory response to ciga-
rette smoke exposure in lungs of Mrp1/Mdr1a/1b  TKO
mice is reduced as compared to WT mice. This is illus-
trated by lower numbers of inflammatory cells in lung sec-
tions as well as by lower levels of IL-8 and G-CSF in total
lung extracts. This is the first study that reports lower
smoke-induced pulmonary inflammation in relation to
absence of ABC transporters. In addition, the expression
levels of several cytokines and chemokines were also
lower in lungs of TKO mice independent of smoke expo-
sure.
A possible explanation of the lower inflammatory
response in TKO mice is an impaired transport of the pro-
inflammatory mediator LTC4, an important physiological
high-affinity substrate for MRP1 [10]. In a study with
inoculation of Streptococcus pneumoniae, Mrp1 (-/-) mice
displayed a better survival compared to WT mice. This was
accompanied by a lower LTC4 concentration but a higher
LTB4 level in bronchoalveolar lavage fluid [17]. In con-
trast, the outgrowth of Mycobacterium tuberculosis was
enhanced in Mrp1 (-/-) mice [18]. Other interesting obser-
vations are that it has been shown that MRP1 regulates the
migration of dendritic cells by transporting LTC4, which
acts as a chemoattractant for dendritic cells to lymph
nodes [19]. The differentiation of dendritic cells is also
dependent on MRP1 function [20]. Furthermore, in
Mdr1a (-/-) mice, migration of dendritic cells to draining
lymph nodes is impaired [21]. The above-mentioned
observations on dendritic cells may contribute to the
decreased inflammatory response following smoke expo-
sure that we measured in lungs of TKO mice.
IL-8 levels were markedly decreased upon smoke exposure
in lungs of TKO mice. IL-8 is induced by smoking and ele-
vated in lungs of COPD patients [22]. It is mainly excreted
by neutrophils, alveolar macrophages and epithelial cells
Table 1: Cytokines and chemokines in lung homogenates.
Cytokines/Chemokines Values in pg/g lung homogenate (mean (SD)) P-values
WT-NSm WT-Sm TKO-NSm TKO-Sm Smoke × Genotype 
interaction
Smoke effect Genotype effect
IL-1α 118.4 (38.1) 195.3 (42.8) 120.8 (22.0) 158.6 (40.8) NS 0.00 ↑ NS
IL-1β 54.0 (10.6) 61.5 (12.8) 50.4 (6.6) 51.7 (6.6) NS NS NS
IL-2 87.9 (35.9) 80.3 (20.3) 70.8 (13.3) 80.3 (23.5) NS NS NS
IL-4 4.5 (0.8) 5.0 (0.6) 4.1 (0.6) 4.7 (0.7) NS NS NS
IL-5 23.6 (3.8) 24.4 (7.1) 22.7 (3.6) 23.9 (6.6) NS NS NS
IL-6 45.4 (11.6) 111.7 (58.0) 47.5 (6.0) 76.0 (17.7) NS 0.01 ↑ NS
IL-7 192.1 (26.4) 196.2 (28.0) 162.0 (9.8) 183.2 (24.4) NS NS 0.05 ↓
IL-8 (KC) 147.1 (58.2) 755.2 (448.0) 133.1 (41.1) 291.8 (93.7) 0.05 ↓ 0.01 ↑ 0.01 ↓
IL-9 136.3 (38.4) 123.6 (21.0) 111.3 (25.1) 107.9 (14.5) NS NS NS
IL-10 359.6 (124.4) 359.4 (103.9) 384.4 (186.4) 366.9 (48.4) NS NS NS
IL-12p70 213.9 (30.7) 213.6 (30.6) 173.9 (15.5) 198.9 (21.0) NS NS 0.03 ↓
IL-13 40.3 (5.3) 49.8 (13.8) 36.8 (2.7) 45.9 (7.5) NS 0.02 ↑ NS
IL-15 99.0 (21.7) 108.0 (15.8) 84.9 (7.4) 98.2 (11.9) NS NS NS
IL-17 20.4 (2.5) 34.2 (16.3) 17.6 (1.4) 20.8 (1.8) NS 0.05 ↑ 0.04 ↓
TNFα 14.2 (2.4) 17.7 (2.9) 11.8 (1.9) 13.8 (1.4) NS 0.01 ↑ 0.00 ↓
IFNγ 80.5 (24.4) 73.11 (14.6) 80.0 (25.4) 78.3 (12.6) NS NS NS
G-CSF 24.9 (3.2) 51.3 (24.8) 21.5 (4.7) 27.5 (2.1) 0.10 ↓ 0.02 ↑ 0.03 ↓
GM-CSF 36.2 (5.7) 40.5 (5.4) 30.1 (1.4) 35.4 (5.7) NS 0.03 ↑ 0.01 ↓
IP-10 297.8 (116.5) 431.9 (304.5) 232.9 (108.4) 220.7 (74.1) NS NS NS
MCP-1 38.0 (2.4) 46.9 (7.2) 29.1 (2.0) 48.2 (24.2) NS 0.02 ↑ NS
MIP1α 600.1 (46.4) 657.3 (83.7) 491.3 (42.9) 516.0 (82.1) NS NS 0.00 ↓
RANTES 37.4 (8.7) 50.3 (38.0) 57.1 (43.9) 33.9 (11.4) NS NS NS
WT wild-type; TKO triple knock-out mice; Sm smokers; NSm non-smokers; SD standard deviation; NS not significant. See text for further details.Respiratory Research 2007, 8:49 http://respiratory-research.com/content/8/1/49
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and a chemoattractant for neutrophils. This is consistent
with the decrease in number of macrophages that we
observed in lung tissue of TKO mice after smoke exposure.
Neutrophils were present in low numbers in both WT and
TKO mice, thus, differences in neutrophil recruitment by
IL-8 to the lungs could not be detected. Intriguingly, IL-8
is known to be involved in tissue repair reactions [23] and
both the IL-8 and G-CSF response tended to be lower in
TKO mice. G-CSF has been reported to promote lung
regeneration as well, supposedly by mobilization of bone
marrow derived cells to alveolar tissue [24]. However, the
precise role of IL-8 and G-CSF in COPD development
and/or prevention remains to be investigated. The
decreased excretion of these two cytokines might result in
a delayed lung regeneration mechanism. This question
cannot be answered in this study, as 6 months smoking
was not sufficient to induce emphysema in these WT and
TKO mice (see discussion below).
The main question is whether the reduced inflammatory
response in TKO mice could be related to the develop-
ment of COPD. In a longitudinal study, we recently
reported that COPD patients who stopped smoking had
an increase in inflammatory cells in induced sputum and
we hypothesized that this might actually be beneficial by
augmenting the defense capacity [25]. Therefore, the
decrease in inflammatory response in TKO mice in our
current study could be detrimental instead of beneficial,
but we currently have no further data to support this
hypothesis.
We have previously detected lower MRP1 expression in
bronchial epithelium of COPD patients compared to
healthy matched controls who were all ex-smokers [12].
These results support our original hypothesis that lower
expression is associated with COPD development and
hence we anticipated more detrimental effects of cigarette
smoke in Mrp1 knock-out or Mrp1/Mdr1a/1b TKO mice.
Further support for this hypothesis comes from studies
with NRF2 (nuclear factor-E2 p45-related factor). NRF2, a
transcription factor for many genes that play a role in anti-
Number of lymphoid infiltrates in paraffin sections of lungs of  WT mice and Mrp1/Mdr1a/1b TKO mice that were exposed  to cigarette smoke or air for 6 months Figure 2
Number of lymphoid infiltrates in paraffin sections of lungs of 
WT mice and Mrp1/Mdr1a/1b TKO mice that were exposed 
to cigarette smoke or air for 6 months. The number of 
smoke-induced lymphoid infiltrates in lungs of WT was 
higher compared to TKO mice (interaction, P = 0.02). WT: 
Wild-type; TKO: Mrp1/Mdr1a/1b triple knock-out; Sm: smoker; 
NSm: non-smoker.
Cytokine and chemokine levels in lung homogenates after 6  months smoke or air exposure Figure 1
Cytokine and chemokine levels in lung homogenates after 6 
months smoke or air exposure. (A) IL-8 levels were elevated 
by cigarette smoke in total group (WT and TKO) of smokers 
(P = 0.01). IL-8 levels are higher in the total group (Sm and 
NSm) of WT mice compared to TKO mice (P = 0.01). The 
smoke-induced upregulation of IL-8 in lungs of WT was 
higher compared to TKO mice (interaction, P < 0.05). (B) 
Granulocyte-colony stimulating factor (G-CSF) levels were 
elevated by cigarette smoke in total group (WT and TKO) of 
smokers (P = 0.02). G-CSF levels are higher in the total 
group (Sm and NSm) of WT mice compared to TKO mice (P 
= 0.03). There was a trend to higher smoke-induced upregu-
lation of G-CSF in lungs of WT compared to TKO mice 
(interaction, P < 0.10). (C) TNFα levels were elevated by 
cigarette smoke in total group (WT and TKO) of smokers (P 
= 0.01) and TNFα levels were higher in the total group (Sm 
and NSm) of WT mice compared to TKO mice (P = 0.00). 
There was no difference in upregulation of smoke-induced 
TNFα in lungs of WT versus TKO mice (no interaction). (D) 
MIP1α levels in total group of smokers compared to non-
smokers was not significant, but levels are higher in the total 
group (Sm and NSm) of WT mice compared to TKO mice (P 
= 0.00). There was no difference in smoke-induced upregula-
tion of MIP1α in lungs of WT versus TKO mice (no interac-
tion). WT: Wild-type; TKO: Mrp1/Mdr1a/1b triple knock-out; Sm: 
smoker; NSm: non-smoker.Respiratory Research 2007, 8:49 http://respiratory-research.com/content/8/1/49
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oxidant defense and detoxification processes, was recently
also identified as a transcription factor for MRP1 [26].
Interestingly, the onset of cigarette smoke-induced
emphysema was earlier and the extent of emphysema was
more severe in Nrf2 (-/-) mice than in wild-type mice [27].
The number of inflammatory cells (mainly macrophages)
in bronchoalveolar lavage fluid and lung tissue was higher
in Nrf2 (-/-) mice. The absence of only the two proteins
Mrp1 and P-gp in our knock-out model compared to the
absence of the transcription factor NRF2 that regulates
many genes involved in oxidative defense, may explain
differences in outcome of this study and ours.
The smoke induced pulmonary infiltrates consisted of B-
cells surrounded by T-cells and macrophages. Hogg et al.
observed such follicles in the small airways of humans
with COPD [28] and we described these B-cell follicles in
our smoking mouse model of emphysema and in lung
parenchyma of patients with COPD [15]. We hypothe-
sized that these B-cells secrete antibodies directed against
extracellular matrix proteins or tobacco smoke compo-
nents but the source of the antigen(s) remains to be eluci-
dated. D'hulst and colleagues have recently shown smoke-
induced emphysema in SCID mice [29]. They suggested
that functional B- and T-cells are not required to induce
emphysema but, as they also point out, this does not
exclude the possibility that the lymphoid follicles could
contribute to loss of alveolar tissue and the decline in lung
function in COPD patients.
We did not observe emphysema in both WT and TKO
mice after 6 months of smoke exposure. With the same
smoke exposure protocol, we have successfully induced
emphysema in C57BL/6J mice [15]. Possibly, FVB mice
are more resistant to smoke-induced emphysema than
C57BL/6J mice, as differences in vulnerability are known
to occur between mouse strains [30,31]. To measure dif-
ferences in alveolar destruction or lung cancer, smoke
exposure for a longer period of time or higher smoke
doses may be required. We used the Lmi method for eval-
uation of emphysema development that measures air
space enlargement only. Lmi is an artificial measurement
Emphysema measurement with the Lmi method in mice that  were exposed to cigarette smoke or air for 6 months Figure 4
Emphysema measurement with the Lmi method in mice that 
were exposed to cigarette smoke or air for 6 months. Paraf-
fin sections were stained with H&E and digital images (19 to 
32 images per lung) were morphometrically analyzed. No sig-
nificant differences were measured between the four groups, 
although a slight increase in airspace size was detected in 
both WT and TKO mice that were exposed to smoke. WT: 
Wild-type; TKO: Mrp1/Mdr1a/1b triple knock-out; Sm: smoker; 
NSm: non-smoker; Lmi: mean linear intercept.
Histological pictures of paraffin sections of lungs of WT mice  (A, C and E) and Mrp1/Mdr1a/1b TKO mice (B, D, and F)  that were exposed to cigarette smoke for 6 months Figure 3
Histological pictures of paraffin sections of lungs of WT mice 
(A, C and E) and Mrp1/Mdr1a/1b TKO mice (B, D, and F) 
that were exposed to cigarette smoke for 6 months. (A, B) 
H&E staining of lungs of WT and TKO mice. In WT mice 
there were markedly more inflammatory infiltrates than in 
lungs of TKO mice. Two types of infiltrates could be distin-
guished in paraffin sections, infiltrates mainly consisting of 
pigmented (smoke particles positive) macrophages (m) and 
infiltrates mainly consisting of lymphoid (ly) cells. (C, D) 
Lymphoid infiltrates mainly consisted of B-cells (B220 anti-
body) which were far more present in lungs of WT mice 
compared to TKO mice, see arrows. (E, F) Pigmented mac-
rophages stained positive with specific antibodies (Mac-3), 
and were far more present in lungs of WT mice compared to 
TKO mice, see arrows. Scale bar = 25 µM.Respiratory Research 2007, 8:49 http://respiratory-research.com/content/8/1/49
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of frequency of presence of structures like alveolar walls.
Several other methods can be used to measure features of
emphysema including "destructive index" and "internal
surface area". These methods capture other aspects of
emphysema but have high correlations with Lmi. How-
ever, they are considerably more time consuming. Since
the results on Lmi were so clearly negative, we chose not
to invest in an additional method that most probably
would not provide different information; we are unaware
of studies with significant differences in one method, that
did not even give a trend in another method of emphy-
sema measurement. 
We questioned whether the lack of Mrp1/Mdr1a/1b would
be compensated for by induction of expression of other
MDR proteins of the ATP-binding cassette family i.e.
Mrp2, 3, 4, 5, 6, 9 and breast cancer resistance protein
(Bcrp). The immunohistochemical expression of these
transporters was low or absent, except for Mrp3 which was
expressed at the apical side of bronchial eptihelium of FVB
mice, however, this may be due to an aberrant staining of
this antibody (M3II-2) as other antibodies for Mrp3 were
negative in human and mice lung tissue [4]. We observed
no differences in expression of all these transporters in
Mrp1/Mdr1a/1b triple knockout mice compared to wild-
type mice, nor did we observe effects of smoking on
expression of Mrp1 and P-gp in WT mice or on all other
analyzed transporter proteins in lungs of both WT and
TKO mice (data not shown). These results indicate that
indeed Mrp1 and P-gp are the most important transport-
ers present in the lung and that cigarette smoke exposure
did not up- or downregulate expression of MDR proteins.
Conclusion
The pulmonary inflammatory response to inhalation of
cigarette smoke is reduced when Mrp1 and both genes for
P-gp are nonfunctional. This includes in particular a poor
ability for smoke-induced IL-8 (and G-CSF) production in
Mrp1/Mdr1a/1b TKO mice compared to WT mice and alto-
gether, this leads to almost complete absence of inflam-
matory cells in response to cigarette smoke. An impaired
function of MRP1 and/or P-gp may result in insufficient
clearance of noxious matter as well. Further research
should clarify whether there is a relation between a
reduced inflammatory response and impaired tissue
repair and thus to an increased risk of developing COPD.
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